At present, multiple studies have confirmed that the immune response resulting due to many tumors, including those found in bladder cancer, is related to the level of immune cell infiltration in the tumor microenvironment, the expression of PD-1/PD-L1, and the tumor mutation burden (TMB) (7, 8). The gene discussed is CD274; the disease is urinary bladder cancer.